pharmaceuticals

Documents about pharmaceuticals

• Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets#843594ClinicalTrials.gov
• Microchip capillary electrophoresis assays and reagents — Regeneron Pharmaceuticals, Inc. (US11054389B2)#607733Google Patents
• Nasal drug products and methods of their use — Opiant Pharmaceuticals, Inc. (US20210275519A1)#607364Google Patents
• W15QKN21C0014 — REGENERON PHARMACEUTICALS INC — Department of Defense ($5,565,000,000)#604362USAspending
• W911QY20C0119 — ASTRAZENECA PHARMACEUTICALS LP — Department of Defense ($1,107,934,203)#605053USAspending
• Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fasting Conditions#845875ClinicalTrials.gov
• CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and … — Vertex Pharmaceuticals Incorporated (US20250041349A1)#653949Google Patents
• Pharmaceuticals#127278PhilArchive
• Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions#349918ClinicalTrials.gov
• Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions#471434ClinicalTrials.gov
• SEC 8-K — InMed Pharmaceuticals Inc. (INM) (0001213900-24-056807) · filed 2024-06-28#608703SEC EDGAR
• SEC 10-K — ALNYLAM PHARMACEUTICALS, INC. (ALNY) (0001178670-22-000013) · filed 2022-02-10#608706SEC EDGAR
• SEC 10-Q — ALNYLAM PHARMACEUTICALS, INC. (ALNY) (0001178670-24-000041) · filed 2024-08-01#608733SEC EDGAR
• SEC 10-Q — ALNYLAM PHARMACEUTICALS, INC. (ALNY) (0001178670-23-000011) · filed 2023-05-04#608734SEC EDGAR
• SEC 8-K/A — Ampio Pharmaceuticals, Inc. (AMPE) (0001193125-11-003202) · filed 2011-01-07#608784SEC EDGAR
• SEC 10-Q — NRX Pharmaceuticals, Inc. (NRXP, NRXPW) (0001558370-21-015962) · filed 2021-11-15#608670SEC EDGAR
• SEC 10-Q/A — NRX Pharmaceuticals, Inc. (NRXP, NRXPW) (0001558370-22-013518) · filed 2022-08-12#608672SEC EDGAR
• Improving healthcare supply chains and decision making in the management of pharmaceuticals#489310LSU Digital Commons
• HHSO100201700016C — REGENERON PHARMACEUTICALS INC — Department of Health and Human Services ($695,741,476)#605719USAspending
• First in Man Study With SLV341#417470ClinicalTrials.gov
• Drug Utilisation of Mysimba/Contrave#807729ClinicalTrials.gov
• Metformin ER 750 mg Tablets, Fed#18533ClinicalTrials.gov
• Metformin ER 750 mg Tablets, Fasting#143793ClinicalTrials.gov
• Technology Specificity and Equitable Access to Pharmaceuticals#248184OSF
• Global Responses: The Search for Cures in the Development of Pharmaceuticals#493930Digital Repository @ Maurer Law
• Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)#825220ClinicalTrials.gov
• Price, Property and Trade Across a Regulatory Border: Pharmaceuticals (Re)importation from Canada and Beyond#641626DigitalCommons@UM Carey Law
• RBL001/RBL002 Phase I Clinical Trial#136413ClinicalTrials.gov
• IVAC MUTANOME Phase I Clinical Trial#150370ClinicalTrials.gov
• REGN5381 in Adult Participants With Uncontrolled Hypertension#414390ClinicalTrials.gov
• Towards a greener pharmaceuticals' regulatory highway#416978World Health Organization
• Cortiment® MMX Pharmacokinetic Study#800521ClinicalTrials.gov
• The Effect of a Probiotic on Hepatic Steatosis#152606ClinicalTrials.gov
• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia#162377ClinicalTrials.gov
• VEL-101 to Prevent Rejection After Kidney Transplantation#162404ClinicalTrials.gov
• Aliskiren Study of Safety and Efficacy in Senior Hypertensives#180228ClinicalTrials.gov
• Perindopril Amlodipine for the Treatment of Hypertension#272436ClinicalTrials.gov
• Adult Subjects With Uncontrolled Type 2 Diabetes#311046ClinicalTrials.gov
• CHART-C3G/CLNP023B12011#414401ClinicalTrials.gov
• Microbial growth in small-volume pharmaceuticals#482380Enlighten Publications
• Extended Use of ModraDoc006/r#833894ClinicalTrials.gov
• Pharmaceuticals and personal care products in the environment: agents of subtle change?#7483OpenAlex
• A Study to Evaluate ALN-AGT01 in Patients With Hypertension#303607ClinicalTrials.gov
• Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes#426757ClinicalTrials.gov
• Valacyclovir 1000 mg Tablet Under Fed Conditions#811751ClinicalTrials.gov
• 52-week Open Label Safety-Tolerability Study#830078ClinicalTrials.gov
• B-FREE Chronic Babesiosis Study#836921ClinicalTrials.gov
• Everolimus in de Novo Heart Transplant Recipients#839170ClinicalTrials.gov
• Clinical Potential of GIP in Type 2 Diabetes and Obesity.#178991Apollo
• Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed#152357ClinicalTrials.gov